NCT06313151招募中不适用
The 2019 EULAR/ACR Classification Criteria as Predictor of Organ Damage in Systemic Lupus Erythematosus Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- prediction organ damage in SLE by using 2019 EULAR/ACR classification criteria.
研究概览
简要总结
The goal of this observational study is to investigate if the 2019 EULAR/ACR classification criteria can be used to assess organ damage in patients with systemic lupus erythematosus (SLE) and as predictor for prognosis .
详细描述
The study will include 200 systemic lupus patient attending Sohag University Hospital from march 2024 to march 2025 in Rheumatology Department.
The patients included in the study will be classified as SLE patient according to 2019 ACR/EULAR classification criteria.
Inclusion criteria:
- Patient age is above 16 years old
- Patient is classified as SLE patient according to 2019 ACR/EULAR classification criteria
- patient with disease duration more than 6 month.
Exclusion criteria:
研究设计
- 研究类型
- Observational
- 观察模型
- Case Crossover
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 16 Years 至 60 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient age is above 16 years old
- •Patient is classified as SLE patient according to 2019 ACR/EULAR classification criteria
- •patient with disease duration more than 6 month.
排除标准
- •Patient with drug-induced lupus and those with systemic sclerosis or dermatomyositis overlap syndromes .
- •patient with disease duration less than 6 month will be excluded.
结局指标
主要结局
prediction organ damage in SLE by using 2019 EULAR/ACR classification criteria.
时间窗: wihe in 18 months
次要结局
未报告次要终点
研究者
Aliaa Abdelhameed
Assistant lecturer
Sohag University
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural EffusionsRespiratory DiseaseLung CancerPleural EffusionNCT03661801University of Oxford313
Unknown
不适用
A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck CancersHead and Neck CancerNCT01936376Foundation for the National Institutes of Health150
已完成
不适用
Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human SubjectsCovid19NCT04667442Nanomix137
Unknown
不适用
Identification of Parameters in rapId-proGression Subgroup Patients With Moderate Aortic StenosisAortic StenosisNCT01575249Carol Davila University of Medicine and Pharmacy200
已完成
不适用
Retrospective Study on Data Aiming to Establish a Prediction Score for Return Home at the Time of Admission to a Multidisciplinary Medical Department (SCORDOMContinuity of Patient CareNCT06288295Elsan600